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ABSTRACT
Purpose: To evaluate the accuracy of electron beam dose calculations in MVCT images containing lead
alloy masks.
Method and Materials: A phantom consisting of two 30x30x5 cm3 slabs of CIRS plastic water® was
imaged using kVCT (GE Lightspeed-RT) and MVCT (TomoTherapy Hi·Art). Nine MVCT scans were
taken with different square masks of lead alloy (Cerrobend®, density = 9.4 g·cm-3) on top of the phantom.
The masks contained square apertures of 3x3 cm2, 6x6 cm2 and 10x10 cm2 and had thicknesses of 6 mm, 8
mm and 10 mm. The same collimation was simulated in the kVCT images by creating regions-of-interest
(ROI) duplicating the sizes, shapes, and density of the masks. Using the Philips Pinnacle3 treatment
planning system, twelve treatment plans were created for the combination of four electron energies (6, 9,
12, and 16 MeV) and the three apertures. For each plan, the mask thickness appropriate for the electron
energy was used and the dose distributions calculated using the kVCT and MVCT images were compared.
In uniform dose regions dose differences were calculated; in high dose-gradient regions distances-toagreement (DTA) were measured.
Results: In the uniform dose region, the maximum differences of doses in the MVCT images from doses
in the kVCT images were greater than or equal to ±5% for all but one opening and energy combination. In
the high dose-gradient region, more than half of the maximum DTA values exceeded 2 mm. Analysis of
the MVCT images showed that the differences were largely due to two errors. First, the presence of the
masks caused distortions in the MVCT numbers such that the calculated dose in the MVCT images
penetrated less deeply. Second, distortion in the shape of the image of the collimation caused the
calculation algorithm to scatter excess electrons into the central axis of the beam.
Conclusion: The presence of Cerrobend® masks in MVCT imaging produces distortions in the CT
numbers that make electron beam dose calculations insufficiently accurate for electron beam treatment
planning.
Supported in part by a research agreement with TomoTherapy, Inc.
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Chapter 1 Introduction
1.1 Function of skin collimation in treatment delivery
Surface (skin) collimation is often used in electron beam therapy for the purposes of sparing
critical structures adjacent to the target by shaping the radiation beam and blocking leakage dose due to
scattered electrons (Hogstrom et al 1991). Skin collimation is also used in conjunction with off-surface
bolus (scatter plate) to restore the sharp beam penumbra after the beam has been scattered and the energy
degraded by the scatter plate (Hogstrom et al 1991). Because of the superficiality of some cancers in the
head and neck region and the importance of avoiding nearby critical structures, skin collimation is most
often used in the treatment of cancers in this area. Cancers in the head and neck most often treated with
electrons and requiring collimation include basal cell and squamous cell carcinomas of the eyelids, lip, tip
of nose and ear (Tapley et al 1976). The accurate positioning of skin collimation within the beam is very
important when setting up the patient for treatment. The skin collimation must have its inner edge inside
the penumbra cast by the geometric (light) field edge of the uncollimated beam and its outer edge must
extend well past the geometric field edge (Hogstrom et al 1991). This maintains the dose uniformity within
the treatment field by narrowing the penumbra and, where used in conjunction with a scatter plate, protects
the patient from dose from scattered electrons (Hogstrom et al 1991).
1.2 Incorporating skin collimation in treatment planning
For accurate dose calculation, the skin collimation must be accurately included in the treatment
planning process. Current commercial treatment planning systems have neither accurate nor efficient
method for doing this because of software limitations and problems in imaging with skin collimation.
There are two straightforward potential methods for adding skin collimation into the treatment
planning process. The first method, currently used in the Mary Bird Perkins Cancer Center (MBPCC), is to
manually draw the skin collimation onto the transverse CT images as an anatomic structure after the scan
(Fig 1). After the structure has been created, its density can be changed to that of Pb (11.3 g·cm-3) or
Cerrobend® (9.4 g·cm-3). However, this process is subjective, inaccurate, and time consuming. To my
knowledge, no commercial treatment planning systems presently have software capabilities for easily
adding skin collimation so that contours must be entered manually, slice by slice. The skin collimation can
be contoured by following the outline of the patient surface which is clearly seen on the CT image (Fig 1).
Most importantly, the beam-defining edges of the collimator must be correct on every slice, matching the
daily setup. Uniformity of thickness of the collimation is not important so long as it stops the electron (in
the clinic the actual masks used for daily treatments are of uniform thickness). The minimum thickness
must equal or exceed the range of the electrons for the energy of the electron beam. Similarly, treatment
planning systems have no methods for modeling the scatter plate so that it must be manually contoured, a
task even more difficult than drawing the skin collimation. However, the problem of the scatter plate is not
addressed in this research.

beam direction

skin
collimation

scatter plate

Figure 1. Skin collimation and scatter plate drawn onto the kVCT images in the treatment planning system.
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A possible second method is to CT scan the patient with the constructed skin collimation in place
so that it is contained in the image set. However, there is a physical limitation to the accuracy of this
solution with conventional CT scanners because of the low photon energy of kVCT. Kilovoltage photons
are greatly attenuated in the presence of high-Z materials such as Cerrobend® so that detector signals are
very small for paths that transverse such materials (Coolens et al 2003). This high attenuation is not well
modeled by conventional CT image reconstruction algorithms, resulting in extreme distortions and streak
artifacts in the images (Yazdia et al 2005) (Fig 2). Dose calculations will therefore be inaccurate when
using kVCT images acquired with skin collimation in place.

(a)

(b)

Figure 2. (a) Axial kVCT image of a CIRS plastic water® phantom with 1cm of Cerrobend® on top,
demonstrating the streaking and distortions produced in kVCT images by high-Z materials; (b) photograph
of phantom and Cerrobend®.
1.3 MVCT as a potential solution to treatment planning with skin collimation
It has been observed that high-density materials (e.g. aluminum, titanium, and copper) produce
dramatically less distortion in MVCT images than in kVCT images (Ozer et al 2006, Meeks et al 2006). A
potential solution to part of the problem of treatment planning with skin collimation is to scan the patient
with the skin collimation in place using MVCT. This would avoid the inaccurate and time consuming
process of manual contouring. Megavoltage photons are less attenuated by high-Z materials such as
Cerrobend®, which means that more photons penetrate the skin collimation and are registered by the
detectors. This produces more accurate reconstruction with conventional algorithms, giving more accurate
CT numbers and less streaking artifacts. MVCT image sets are also more relevant for treatment planning
because the CT numbers are directly related to electron density, making them more relevant than kVCT for
dose calculations and inhomogeneity corrections (Ruchala et al 1999).
The TomoTherapy Hi·Art® system, one of which is owned by MBPCC, has an onboard MVCT
scanner (3.5 MV) for image guided radiation therapy (IGRT). It is capable of scanning a patient and
sending the images to a Philips Pinnacle3 treatment planning system (TPS) for dose calculations. Figure 3
shows an image of the same setup as Figure 2 (plastic water® phantom with skin collimation) taken with
TomoTherapy MVCT. The amount of streaking and image distortion normally due to high-Z Cerrobend®
is dramatically reduced, clearly highlighting MVCT’s potential usefulness. This improvement in image
quality could potentially enable Monte Carlo algorithms or a recommissioned pencil beam redefinition
algorithm (PBRA) to correctly calculate dose in the presence of multiple beam modifiers such as skin
collimation and scatter plate.
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Figure 3. Axial MVCT image of a CIRS plastic water® phantom with 1cm of Cerrobend® on top,
demonstrating reduced streaking and distortions in MVCT images with high-Z materials.
1.4 Purpose
The goal of this research is to investigate the use of MVCT imaging of phantoms with skin
collimation in place for the purpose of electron beam treatment planning.
1.5 Hypothesis
The hypothesis of this research is that using MVCT images with skin collimation for treatment
planning, doses delivered from 6-16 MeV electron beams can be calculated to ±5% dose difference
agreement in the uniform-dose region and ±2mm distance-to-agreement in high dose-gradient regions
compared to doses calculated using kVCT images with manually contoured skin collimation. The uniform
dose region is defined as those doses >90% of the maximum dose along the central axis for a 10x10 cm2
open field at 100 cm SSD and the high dose-gradient region is defined as 10%<doses<90% of the
maximum dose along the central axis for a 10x10 cm2 open field at 100 cm SSD.
1.6 Specific aims
Aim 1. Construct CT number-to-density tables for MVCT and kVCT images.
Aim 2. Compare dose calculations in MVCT and kVCT images of a plastic water phantom
without skin collimation.
Aim 3. Compare dose calculations in MVCT and kVCT images of a head phantom and patient
without skin collimation.
Aim 4. Construct Cerrobend® masks to simulate the range of dimensions of skin collimation used
in the clinic.
Aim 5. Compare doses calculated on MVCT images of a plastic water® phantom with skin
collimation in place to doses calculated on kVCT images of the same phantom with skin
collimation drawn onto the images during treatment planning.
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Chapter 2 Aim 1
2.1 Aim 1: Construct CT number-to-density tables for MVCT and kVCT images
TomoTherapy MVCT images are currently used for image-guided radiation therapy (IGRT) at
MBPCC but not for clinical dose calculations. Consequently, there is no clinically available CT numberto-density conversion table. The purpose of this aim was to generate MV and kV CT number-to-density
conversion tables for the dose calculations in Aims 2, 3 and 5.
2.2 Methods and materials
A CIRS model 062 electron density phantom was scanned. This phantom is composed of an outer
‘torso’ and an inner ‘head’ section and has a series of plugs of known physical densities (Figs 4, 5). A CT
scan of the phantom provided a relationship between CT number and physical density for both kVCT and
MVCT images. The relationships are tabulated and entered into Pinnacle3 for its dose calculations.
insert

Figure 4. CIRS model 062 phantom.
2.2.1 MVCT density tables
To create a measured MVCT number-to-density table, the CIRS ‘torso’ phantom was scanned two
consecutive times using the “Fine” slice thickness (2 mm) on the TomoTherapy unit. The whole ‘torso’
was scanned rather than simply the ‘head’ in order to include the maximum number of inserts. The
resulting images were transferred to Pinnacle3. Using the contouring tools of Pinnacle3, a circular regionof-interest (ROI) was created within the image of each insert (Fig 5). The ROI was at least 5 mm in
diameter and no bigger than 15 mm in diameter in order to sample a large number of pixels at the center of
the insert and to avoid CT number variations at the edges of the 29.5-32.5 mm inserts. Pinnacle3 calculated
and reported the mean CT number in each ROI. The reported CT numbers from the two sets of scans were
averaged and used to create a CT number-to-density table.
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region-ofinterest on
insert

Figure 5. Axial MVCT image of CIRS model 062 electron phantom.
To minimize the effect of possible fluctuations in CT numbers between measurement days, scans of
the CIRS phantom to generate CT number-to-density conversion tables were performed on the same days
as the image sets were acquired for dose calculations. A total of four separate tables were created.
2.2.2 kVCT density tables
The CIRS phantom was scanned on the GE Lightspeed RT scanner to produce a kVCT number-todensity conversion table (Fig 6). The scanner was set at 120kVp and the slice thickness was 2.5 mm
instead of 2 mm. The average of two scans taken on the same day was used for the CT numbers.

Figure 6. Axial kVCT image of CIRS model 062 electron phantom
2.3 Creation of aim-specific CT number-to-density tables
Three of the four tables created for the MVCT image dose calculations and the one table created
for the kVCT image dose calculations were modified in order that the CT number for plastic water
correctly predict its collision stopping power ratio. In calculating electron beam doses, Pinnacle3
determines collision stopping power and angular scattering power ratios from physical density, which is
determined from a CT number. Therefore, the physical densities in the CT number-to-density tables were
altered to relate the proper collision stopping power and angular scattering power ratios to CT numbers.
The stopping power for water (S/ρ)water for electrons is 1.968 MeV·g-1·cm2 and the stopping power for CIRS
plastic (S/ρ)plastic for electrons is 1.971 MeV·g-1·cm2. This results in a relative stopping power of 1.002,
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which in the Pinnacle3 lookup table corresponds to a density of 0.981 MeV·g·cm-3 (Table 1). Therefore, in
order for Pinnacle3 to use the correct stopping power and angular scattering power ratios for the phantom
calculations in Aims 2, 3 and 5, the densities in the CT number-to-density tables were modified by a
correction factor that produced a density value of 0.981 for the phantom density.
Table 1. Patient collision stopping power and angular scattering power data.
Physical Density
Collision Stopping Power Ratio
(g·cm-3)
Angular Scattering Power Ratio
0.000
0.001
0.001
0.291
0.311
0.292
0.927
0.933
0.729
1.000
1.027
0.912
1.047
1.051
1.040
1.100
1.098
1.135
1.427
1.422
1.863
1.940
1.940
3.026
2.900
11.300
11.900
2.3.1 Aim 2 and Aim 5 modified tables
The modified MVCT number-to-density table used for Aim 2 was created from the table measured
on November 21, 2006. A CIRS plastic water® phantom, consisting of two slabs of size 30x30x5 cm3, was
scanned on the same day and an ROI was drawn in the center to obtain a mean CT number. The mean CT
number was 1032, which corresponded to a density value of 1.020 g·cm-3. Therefore, the densities in the
range from 0.967 g·cm-3 to 1.07 g·cm-3 were scaled by a factor of 0.964 (=0.981/1.020). This same factor
was applied to the same range of densities for the MVCT number-to-density tables used for the dose
calculations done in Aim 5.
The modified kVCT number-to-density table used for Aim 2 was similarly modified. The mean
CT number measured for the plastic water phantom was 1075, which corresponded to a density value of
1.080 g·cm-3. Therefore, densities in the kVCT table in the range from 0.495 g·cm-3 to 1.16 g·cm-3 were
scaled by a factor of 0.910 (=0.981/1.080).
2.3.2 Aim 3 modified tables
The modified MVCT number-to-density table used for Aim 3 was created from the table measured
on November 28, 2006. The CIRS model 065 radiosurgery head phantom was scanned on the same day
and an ROI drawn in a section of soft tissue to obtain a mean CT number. The mean CT number was 1066,
which corresponded to a density value of 1.063 g·cm-3. Therefore, the densities in the range from 0.967
g·cm-3 to 1.07 g·cm-3 were scaled by a factor of 0.923 (=0.981/1.063).
The modified kVCT number-to-density table was created in the same way except that the mean
CT number was 1032, which corresponded to a density value of 1.032 g·cm-3. Therefore, densities in this
table in the range from 0.967 g·cm-3 to 1.07 g·cm-3 were reduced by a factor of 0.950 (=0.981/1.03).
2.4 Results
Four MVCT number-to-density conversion tables were measured and three modified tables were
created. Each table was date-specific, meaning that it was used to calculate doses only for the images
acquired on the same day as the measurement of the table. The measured tables show good consistency
over the fifteen days that the data were acquired (Table 3). The table used to calculate dose in the patient
(November 13, 2006) was not modified. The modified data are shown in Table 3. The measured kVCT
number-to-density conversion table and its modified version are shown in Table 4.
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Table 2. MV CT number-to-density data.
CT
number
Nov, 17
2006
0
4
232
508
974
1011
1020
1064
1077

CT
number
Nov, 21
2006
0
4
232
504
974
1008
1017
1061
1076

CT
number
Nov, 28
2006
0
1
232
507
977
1013
1019
1065
1080

Mean and
standard

Density (g·cm-3)
0
0.001
0.195
0.495
0.967
0.991
1.000
1.062
1.071

CT
number
Nov, 13
2006
0
2
231
504
974
1008
1022
1060
1076

1.161
1.609

1148
1504

1148
1508

1146
1506

1151
1507

1148 ± 2.1
1506 ± 1.7

Physical
Material
vacuum
air
lung (inhale)
lung (exhale)
adipose
breast
water
muscle
liver
trabecular
bone
dense bone

deviation
0±0
3 ± 1.5
232 ± 0.5
506 ± 2.1
975 ± 1.5
1010 ± 2.5
1020 ± 2.1
1063 ± 2.4
1077 ± 1.9

Table 3. Modified MV CT number-to-density tables.
Aim 2 modified
physical density
Physical
(g·cm-3)

Aim 3 modified
physical density
(g·cm-3)

Aim 5 modified
physical density
(g·cm-3)

Aim 5 modified
physical density
(g·cm-3)

density (g·cm-3)
0.000
0.001
0.195
0.495
0.967
0.991
1.000
1.062
1.071
1.161
1.609

Nov 28, 2006
0.000
0.001
0.195
0.495
0.893
0.915
0.923
0.980
0.989
1.161
1.609

Nov 17, 2006
0.000
0.001
0.195
0.495
0.933
0.956
0.965
1.025
1.034
1.161
1.609

Nov 28, 2006
0.000
0.001
0.195
0.495
0.932
0.955
0.964
1.024
1.032
1.161
1.609

Material
vacuum
air
lung (inhale)
lung (exhale)
adipose
breast
water
muscle
liver
trabecular bone
dense bone

Nov 21, 2006
0.000
0.001
0.195
0.495
0.929
0.952
0.961
1.021
1.029
1.161
1.609
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Table 4. Measured and modified kV CT number-to-density data.
Aim 2 modified
Physical
physical
-3
Material
CT number
density (gcm )
density (gcm-3)
vacuum
0
0
0
air
2
0.001
0.001
lung (inhale)
223
0.195
0.195
lung (exhale)
495
0.495
0.479
adipose
939
0.967
0.880
breast
976
0.991
0.902
water
1008
1.000
0.910
muscle
1054
1.062
0.966
liver
1062
1.071
0.975
trabecular
bone
1242
1.161
1.057
dense bone
1927
1.609
1.537
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Aim 3 modified physical
density (gcm-3)
0
0.001
0.195
0.495
0.919
0.941
0.950
1.009
1.017
1.161
1.609

Chapter 3 Aim 2
3.1 Aim 2: Compare dose calculations in MVCT and kVCT images of a plastic water phantom
The goal of Aim 2 was to determine the accuracy of electron dose calculations when using MVCT
images of a plastic water phantom with no skin collimation (no high-Z distortions).
3.2 Methods and materials
Two slabs of 30x30x5 cm3 CIRS plastic water® were stacked on top of each other to produce a flat
surface, water-like phantom that could easily be CT scanned on the GE Lightspeed RT and on the
TomoTherapy MVCT unit. This phantom was scanned once on each machine, and the resulting image sets
were exported to Pinnacle3 (Fig 7).

Figure 7. Axial MVCT image of a CIRS plastic water phantom image with the geometry of a 10x10 cm2
beam.
3.2.1 Treatment planning
Two simple treatment plans were created on each image set. The first plan was a 9 MeV beam
perpendicular to the phantom with an open 10x10 cm2 applicator and a prescription of 100 monitor units
(MUs) delivered at 100 cm SSD. The second plan had the same parameters and prescription except its
energy was 16 MeV. Calculated doses were extracted from the kVCT and MVCT image sets by aligning
the posterior edge of the dose grid to the posterior edge of the phantom in order to avoid surface distortion
(Figure 8). The dose grid had the same dimensions for each set of images.
The vertical coordinate of the posterior edge of the phantom in both image sets was determined
using a two step process. First, the couch was removed from the image set by contouring an ROI aligned to
the surface of the couch and overriding the density to be that of air. Second, a point-of-interest (POI) and a
posterior beam were created. The beam isocenter was set at the POI and then the SSD of the beam was set
to 100 cm (Figure 8). Pinnacle3 has a default threshold density value of 0.60 g/cm3 for identifying the
surface of the patient. In determining SSD, Pinnacle3 ray-traces along the central axis of the beam from the
source until it encounters a voxel with density above the threshold value. Therefore, the first central-axis
voxel with density above the threshold was taken as the posterior edge of the phantom. This method was
used because it puts the dose grid in the same position relative to the phantom regardless of possible
distortions in the anterior surface.

couch

region-of-interest

isocenter

phantom

Figure 8. CT scan of plastic water phantom in which the couch was removed by setting its density to 0.000
g·cm3. The isocenter point is the intersection of a posterior beam at 100 cm SSD with the phantom surface.
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Two-dimensional dose matrices were exported from Pinnacle3 to SigmaPlot®. Isodose curves and
central-axis depth-dose curves were generated in SigmaPlot®. For comparison purposes, these curves were
aligned with respect to the back edge of the plastic water®, which corresponded to the back edge of the
dose grid (Figure 9). Because the dose grid was 15.8 cm in the anterior-posterior direction and the
phantom was 10 cm in the same direction, the first 5.8 cm of the dose matrix were subtracted in order to
align the isodose curves. This assured that the 0 cm depth for the depth dose and isodose curves
corresponded to the surface of the plastic water® in the kVCT image set. The following is the equation
used to determine the phantom’s surface (i.e. 0.0 cm in SigmaPlot®) with PS defined as phantom surface,
DG defined as the length of the dose grid in the anterior-posterior direction, PT defined as the phantom
thickness in the same direction and FG defined as the front coordinate of the dose grid, placed at -5.8:
PS = DG – PT + FG.

Figure 9. The dose grid (green dash line) on a kVCT image with the posterior edge at the posterior edge of
phantom.
3.2.2 Comparison methods
For each beam energy, the MVCT isodose distributions and central-axis depth dose curves were
superimposed onto the kVCT curves for visual comparison. Dose differences between the two matrices
were computed in SigmaPlot® by subtracting the MVCT calculated doses from those of the kVCT. Dose
differences were only evaluated in the uniform-dose region. The range of dose differences was extracted
and recorded.
Distance-to-agreement (DTA) was determined for high dose-gradient regions by manual
measurement with a ruler normal to the superimposed isodose distributions. The maximum DTA for each
comparison was recorded. The uniform dose region is defined as those doses >90% of the maximum dose
along the central-axis for a 10x10 cm2 open field at 100 cm SSD and the high dose-gradient region is
defined as 10%<doses <90% of the maximum dose along the central-axis for a 10x10 cm2 open field at 100
cm SSD.
3.3 Results
The superimposed isodose distributions and depth doses are shown in Figures 10-13. The
positions of maximum dose difference are identified with a red ellipse. The positions of maximum DTA
are identified with a blue ellipse. The ranges of dose differences and maximum DTAs are shown in Table
4. As can be seen the dose differences and DTAs fell within the hypothesis criteria for both energies (<5%
and ±2 mm, respectively).
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Figure 10. 9 MeV isodose curves computed on MVCT and kVCT images. The field size was 10x10 cm2
and the SSD = 100 cm.
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Figure 11. 9 MeV percent depth-dose curves for doses computed on MVCT (dashed curve) and kVCT
(solid curve) images.
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Figure 12. 16 MeV isodose curves computed on MVCT and kVCT images. The field size was 10x10 cm2
and the SSD = 100 cm.
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Figure 13. 16 MeV depth-dose curves for doses computed on MVCT (dashed curve) and kVCT (solid
curve) images.

Table 5. Ranges of dose differences in the uniform-dose region and maximum DTAs in high dose-gradient
regions.

Energy
9 MeV
16 MeV

Ranges of dose
differences (%)
(uniform-dose region)
[2.2, -1.3]
[2.3, -1.2]

Maximum DTA (mm) (gradient regions)
0.8
1.2

3.4 Conclusion
The results demonstrated that TomoTherapy MVCT images for a plastic water phantom can
produce electron beam dose calculations clinically equivalent as those produced from kVCT images.
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Chapter 4 Aim 3
4.1 Aim 3: Compare dose calculations in MVCT and kVCT images of a head phantom and patient
The goal of Aim 3 was to evaluate the accuracy of electron beam dose calculations in MVCT
images of an anthropomorphic head phantom and a patient case, both without high-density skin
collimation.
4.2 Methods and materials
A radiosurgery head phantom, CIRS model 605, was chosen to provide a CT data set for phantom
dose calculations (Fig 14). This phantom was scanned once on a GE Lightspeed RT machine (2.5 mm slice
thickness) and once on a TomoTherapy MVCT unit (2.5 mm slice thickness). Both image sets were
exported to a Pinnacle3 workstation for treatment planning (Figs 15, 16). The advantage of using a head
phantom is that the anatomy is physically the same in both the kVCT and MVCT scans and the images
could be taken with the same slice thickness.

Figure 14. Photograph of CIRS model 605 radiosurgery head phantom.

maxillary sinus
zygomatic arch

Figure 15. Axial kVCT image of CIRS model 605 radiosurgery head phantom with labeled anatomy. This
slice was chosen for the central axis of the electron beam.
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maxillary sinus
zygomatic arch

Figure 16. Axial MVCT image of CIRS model 605 radiosurgery head phantom with labeled anatomy.
This slice was chosen for the central axis of the electron beam.
Doses were also calculated on MVCT and kVCT images of a patient. The selected patient had a
squamous cell carcinoma of the floor of tongue, had been scanned on a GE Lightspeed (2.5 mm slice
thickness), and was currently undergoing radiation treatment on the TomoTherapy system. The daily
MVCT scan (4 mm slice thickness) taken for IGRT was selected. Both the kVCT and MVCT images were
exported to a Pinnacle3 workstation. The kVCT image set was changed to make a new image set with a
slice thickness of 5 mm. This was done by averaging two slices to make one. This reduced some of the
potential effects that different slice thicknesses could have on the dose calculation comparison. Because
the two image sets were taken approximately 2 months apart, some anatomical differences were observed
(Figs 17, 18). The clinical kVCT number-to-density conversion table was used for kVCT dose
calculations. The MVCT number-to-density conversion table created on November 13 was used for dose
calculation purposes.
maxillary sinus
zygomatic arch

Figure 17. Axial kVCT image of the patient. This slice was chosen for the central axis of the electron
beam.
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maxillary sinus
zygomatic arch

Figure 18. Axial MVCT image of the patient. This slice was chosen for the central axis of the electron
beam.
4.2.1 Image registration
In Pinnacle3 the two phantom and two patient image sets were manually registered using the
Image Fusion module. The fusion process in Pinnacle3 can be done automatically using a local correlation
algorithm. However, manual registration was used for two reasons. First, both image sets must have the
exact same treatment delivered. Therefore, any rotation during registration must be known exactly because
the angle of the gantry with respect to the image must be the same. The automatic registration algorithm
does not give the rotation information. Second, the software used to generate isodose curves from the
exported dose grid information (SigmaPlot® 9.0) does not have a rotation capability for its two dimensional
contour graphs, so the degree of rotation of the automatic fusion could not be matched even if the amount
were known. In the manual registration process, no rotations were used and the fusion of the images was
done using anatomy in the region of treatment.
4.2.2 Phantom and patient treatment planning
The head phantom and patient CT images were treated with the same setup. The axial slices
chosen for the central axes (CAX) of the beams included both bone and air inhomogeneities and had
anatomy conducive to manual registration of the kVCT and MVCT image sets (Figs. 15-18). Two simple
treatment plans were created on each image set. Both plans were open beams with a 6x6 cm2 applicator at
a gantry angle of 125º and an SSD of 100 cm. One was a 9 MeV beam and the other a 16 MeV beam. The
oblique angle for this beam was chosen to include both bone and air heterogeneities. The prescription was
set to 100 MUs.
Calculated doses were compared in the axial slice containing the isocenter of the beam. Doses
were not evaluated in superior or inferior slices for the patient for two reasons. First, the patient’s head was
not in exactly the same location for both the kVCT and MVCT scans and, therefore, image sets could only
be accurately registered in one slice by using the anatomy in the region of treatment. Second, because the
kVCT and MVCT scans had different slice thicknesses, the closest superior and inferior slices that were at
the same physical locations were 2cm above and below the isocenter. This distance increased the
inaccuracies associated with registration of local anatomy. The dose grid information for each axial slice
was exported to Sigma Plot® and isodose plots were generated.
4.2.3 Comparison methods
The maximum dose differences in the uniform region were calculated by subtracting the MVCT
calculated dose matrix from the kVCT calculated dose matrix and then finding the differences with the
largest absolute values.
4.3 Results
4.3.1 Phantom treatment plans (9, 16 MeV)
Figures 19-24 show the central axis axial slices of the kVCT and MVCT image sets with the
isodose curves, beam profile and isocenter displayed in order to give proper anatomical orientation to the
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corresponding isodose curves displayed in SigmaPlot®. On the SigmaPlot® overlays, the position of
maximum dose difference is indicated by a red ellipse. The position of maximum DTA is indicated by a
blue ellipse.

Figure 19. Axial kVCT image of head phantom with isodose curves, beam profile, and isocenter (9 MeV).

Figure 20. Axial MVCT image of head phantom with isodose curves, beam profile, and isocenter (9 MeV).
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Figure 21. Isodose curve comparison for phantom case (9 MeV). The red ellipse indicates the position of
maximum dose difference. The blue ellipse indicates the positions of maximum DTA.

Figure 22. Axial kVCT image of head phantom with isodose curves, beam profile, and isocenter (16
MeV).
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Figure 23. Axial MVCT image of head phantom with isodose curves, beam profile, and isocenter (16
MeV).

Figure 24. Isodose curve comparison for phantom case (16 MeV). The red ellipse indicates the position of
maximum dose difference. The blue ellipse indicates the positions of maximum DTA.
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The ranges of dose differences in the uniform region were calculated by subtracting the MVCT
calculated dose matrix from the kVCT calculated dose matrix and then finding the differences with the
largest absolute values. The results are shown in Table 6. Both the low energy (9 MeV) and the high
energy (16 MeV) beams meet the hypothesis criteria of ±5% dose difference in the uniform region and ±2
mm DTA in the high dose-gradient region. These results are similar to the plastic water® case.
Table 6. Ranges of dose differences for the head phantom in the uniform region and maximum DTAs in the
high dose-gradient regions.

Energy
9 MeV
16 MeV

Ranges of dose
difference (%)
(uniform-dose region)
[1.2, -2.0]
[4.3, -2.0]

Maximum DTA (mm)
(gradient regions)
0.5
1.0

4.3.2 Patient treatment plans (9, 16 MeV)
Figures 25-30 show the central axis axial slices of the kVCT and MVCT image sets of the patient
with the isodose curves, beam profile and isocenter displayed in order to give proper anatomical orientation
to the corresponding isodose curves displayed in SigmaPlot®.

Figure 25. Patient’s central axis kVCT slice with isodose curves (9 MeV).
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Figure 26. Patient’s central axis MVCT slice with isodose curves (9 MeV).
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Figure 27. Isodose curve comparison for patient case (9 MeV). The red ellipse indicates the position of
maximum dose difference. The blue ellipse indicates the positions of maximum DTA.
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Figure 28. Patient’s central axis kVCT slice with isodose curves (16 MeV).

Figure 29. Patient’s central axis MVCT slice with isodose curves (16 MeV).
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Figure 30. Isodose curve comparison for patient case (16 MeV). The red ellipse indicates the position of
maximum dose difference. The blue ellipse indicates the positions of maximum DTA.
The range of dose differences in the uniform region was calculated by subtracting the MVCT
calculated dose matrix from the kVCT calculated dose matrix and then finding the differences with the
largest absolute values. The results are shown in Table 7. Both the low energy (9 MeV) and the high
energy (16 MeV) beams meet the hypothesis criteria of ±5% dose difference in the uniform region. These
results are similar to the phantom case.
The maximum DTA for doses less than 90% of maximum exceeds ±2 mm for both energies
(Table 7). It is important to note that the DTA which did not meet the ±2 mm criteria were found at the
10% isodose lines. Not only is this region not as clinically relevant as the target region but this disparity
may be the results of anatomical changes. Because the patient was scanned on the Lightspeed machine
approximately 2 months prior to the TomoTherapy unit scan, it is possible that the anatomy changed to the
point where dose calculations were affected. That this is true at least in some regard is seen by examining
the patient’s right maxillary sinus on the kVCT and MVCT scans. In the kVCT image the sinus is partially
filled with fluid while in the MVCT image the fluid is not present. While this does not directly impact the
dose calculation in the region of the target, it suggests that there were changes in anatomy that could have
affected the dose calculations. Also, the difference in slice thicknesses may have caused inaccuracies in the
dose calculations. Results from attempting to quantify this possibility were inconclusive as the patient was
not able to be scanned at 2.5 mm slice thickness on the TomoTherapy unit.
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Table 7. Ranges of dose differences for the patient in the uniform region and maximum DTAs in the high
dose-gradient regions.

Energy

Ranges of dose
difference (%)
(uniform-dose region)
[4.4, -2.4]
[4.0, -2.5]

Maximum DTA (mm)
(gradient regions)
3.0
3.9

9 MeV
16 MeV
4.4 Conclusions
4.4.1 Phantom study
The results for the phantom study indicate that calculated doses from electron beams in complex
geometrical cases are accurate in MVCT images between 9 MeV and 16 MeV. The higher energy case
results were slightly worse than for those of the low energy case but still fell well within the hypothesis
criteria.
4.4.2 Patient study
The results for the patient study suggest that calculated doses from electron beams are not accurate
in MVCT images. Both energies failed the hypothesis criteria in having DTA that were greater than 2mm.
However, it is highly likely that the major cause of the dose disagreements was either a change in the
anatomy between the time of kVCT imaging and MVCT imaging or slice thickness difference. The DTA
values are outside the target, essentially by definition. The dose differences in the target were within ±5%.
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Chapter 5 Aim 4
5.1 Aim 4: Construction of Cerrobend® masks to simulate the range of skin collimation used in the
clinic
Cerrobend® masks were needed for testing MVCT images with skin collimation (Aim 5). Clinically used
masks were studied and a set of representative test masks was made for use in Aim 5.
5.2 Methods and materials
5.2.1 Clinical masks
A typical patient Cerrobend® mask is shown in Fig 31. The important characteristics of a mask
are the opening size, the thickness, and the lateral extent. The opening size is critical and is determined by
the size of the treatment area. The thickness is determined by the beam energy. It must equal or exceed the
minimum thickness needed to stop the electron beam. The lateral extent of the mask is not a precisely
defined dimension. It needs to be large enough to meet the minimum shielding criteria and not so large as
to be uncomfortable for the patient.
lateral extent

opening
Figure 31. Photograph of typical clinical Cerrobend® mask.
However, we expect that the amount of Cerrobend® on the patient will directly impact the quality
of the MVCT image. The size of the opening affects the portion of the CT image in the path of the beam,
with smaller openings having a greater impact than larger openings (Fig 32, 33). Therefore, it is important
to perform testing with masks that represent the range of clinical situations.
skin
collimation

flat surface
plastic water®

Figure 32. Cerrobend® mask with a 10x10 cm2 opening on the surface of CIRS plastic water®.
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skin collimation

bowing affect
plastic water®

Figure 33. Cerrobend® mask with a 3x3 cm2 opening on the surface of CIRS plastic water®.
Twelve clinical Cerrobend® masks used for patient treatment were collected, measured, and
characterized. The opening size was approximated as an ellipse and its major and minor axes dimensions
were measured. The lateral extent was measured at each end of the major and minor axes. Masks with
very small openings, such as those used for treatments involving the eyelid, were not included because in
such cases the monitor units (MUs) are calculated by hand instead of using treatment planning software.
5.2.2 Construction of test masks
Three styrofoam squares were cut by the Compu●cutter® system with sizes of 3x3 cm2, 6x6 cm2
and 10x10 cm2. These squares were placed inside steel frames of size 10x10 cm2, 15x15 cm2 and 15x15
cm2 respectively. Cerrobend® was poured around the foam squares and made to the desired thickness (6
mm, 8 mm, and 10 mm) required for adequate shielding for energies of 6, 9, 12, and 16 MeV (Fig 34).
This process produced a total of nine square masks with clinically relevant opening sizes, lateral extensions
and thicknesses (Table 8).
foam block

Cerrobend®

steel frame

Figure 34. Cerrobend® mask formed within the steel frame and around a styrofoam insert.
Table 8. Constructed mask dimensions.
Mask number
Opening size (cm2)
1
3x3
2
6x6
3
10x10
4
3x3
5
6x6
6
10x10
7
3x3
8
6x6
9
10x10

Lateral extent (cm)
3.5
4.5
2.5
3.5
4.5
2.5
3.5
4.5
2.5
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Thickness (mm)
6
6
6
8
8
8
10
10
10

5.3 Results
The characteristics of the individual clinical masks are given in Table 9. As can be seen, the
dimensions varied considerably. The data are summarized in Table 10, which shows the maximum,
minimum and average values for the lateral extent and opening size. These values guided the dimensions
of the Cerrobend® masks produced in this aim for the tests of Aim 5. Smaller dimensions were chosen for
the lateral extent of the test masks with respect to the clinical sizes because clinical masks are often made
larger than necessary in this region to avoid any possible shielding problems. Examples of the test masks
are shown in Figures 35-38.
Table 9. Dimensions of clinical Cerrobend® masks.
Clincial mask
dimensions
Opening
size (cm)
Mask number
1
2
3
4
5
6
7
8
9
10
11
12

major axis
7.5
8.0
7.0
8.0
11.0
13.0
2.5
4.0
6.0
12.5
4.5
6.0

minor axis
5.0
7.0
6.0
6.0
10.0
6.0
2.0
2.0
6.0
8.0
4.0
3.5

Lateral
major axis
ends
5.0 , 5.5
4.0 , 3.5
4.5 , 4.0
5.0 , 5.0
3.0 , 4.0
4.5 , 3.5
5.0 , 7.0
6.0 , 4.0
6.0 , 6.0
3.0 , 3.0
3.5 , 3.5
3.5 , 4.0

Table 10. Maximum, minimum and mean clinical mask dimensions.
Clinical mask data
Maximum distance (cm)
Minimum distance (cm)
Lateral Extent
major axis
7.0
3.0
minor axis
6.0
3.0
Opening Size
Major axis
minor axis

13.0
10.0

2.5
2.0

Figure 35. Photograph of a mask with
a 3x3cm2 opening.

extent (cm)
minor axis ends
4.5 , 6.0
4.5 , 4.0
4.5 , 4.5
5.0 , 5.0
3.0 , 4.0
5.5 , 5.0
5.0 , 5.5
6.0 , 5.0
6.5 , 5.0
4.0 , 4.0
3.5 , 3.5
4.0 , 4.0

Mean distance (cm)
4.4
4.7

7.5
5.5

Figure 36. Photograph of a mask with a
6x6 cm2 opening.
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Figure 37. Photograph of a mask with
a 10x10 cm2 opening.

Figure 38. Photograph showing a 6 mm
thick mask next to a 10 mm thick mask.
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Chapter 6 Aim 5
6.1 Aim 5: Comparison of dose calculations in MVCT and kVCT images with skin collimation.
The purpose of this aim was to evaluate the accuracy of dose calculations in MVCT images with
skin collimation.
6.2 Methods and materials
Two slabs of 30x30x5 cm3 CIRS plastic water® (density=1.03g·cm-3), used clinically for machine
QA, were stacked on top of each other to provide a simple geometry phantom that could easily be CT
scanned with or without the Cerrobend® masks.
6.2.1 kVCT treatment planning
The two slabs were scanned on a GE Lightspeed RT machine (120 kvp, 2.5 mm slice thickness)
and exported to a Pinnacle3 workstation. In Pinnacle3, regions-of-interest (ROIs) were created on the
surface of the phantom to mimic the nine different masks created in Aim 4 (Fig 39). Because only one
image set was used in Pinnacle3 and a total of nine different treatment fields needed to be simulated, the
treatment planning was performed in stages. After each collimation ROI was formed, the corresponding
treatment field was created, the dose was calculated, and the result was exported to SigmaPlot®.

skin
collimation

®

plastic water
phantom

ROI skin
collimation

(a)

(b)

Figure 39. (a) Axial view of ROI Cerrobend® in kVCT image; beam edges are in red. (b) Beam’s eye view
of ROI Cerrobend® in kVCT image; beam outline is in red.
Two important modifications were made to ensure that the ROIs behaved as skin collimation in
the dose calculations. The first modification required creating a special table in Pinnacle3 for computing
stopping power ratios and scattering power ratios from patient density. Pinnacle3 uses a look-up table to
convert densities to collision stopping power and angular scatter power ratios for the purpose of electron
dose calculation. However, Pinnacle3 limits densities in this table to a maximum value of 3 g·cm-3. This is
not high enough to correctly model Cerrobend®. Collision stopping power and angular scattering power
ratios for Cerrobend® were chosen to be 11.3 and 11.9 respectively based on work done previously by Dr.
Kenneth Hogstrom12. The workaround for this problem was to insert those values into the table for a
corresponding density value of 2.9 g·cm-3 (Table 11). These values would allow Pinnacle3 to terminate the
transport of electrons through the ROIs mimicking Cerrobend®. The second modification was to make the
density of the ROI equal to the highest density value allowed by Pinnacle3 (3 g·cm-3).
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Table 11. Patient collision stopping power and angular scattering power data.
Physical Density
Collision Stopping Power Ratio
(g·cm-3)
Angular Scattering Power Ratio
0.000
0.001
0.001
0.291
0.311
0.292
0.927
0.933
0.729
1.000
1.027
0.912
1.047
1.051
1.040
1.100
1.098
1.135
1.427
1.422
1.863
1.940
1.940
3.026
2.900
11.300
11.900
6.2.2 MVCT treatment planning
The two slabs were also scanned with each of the nine Cerrobend® masks on the TomoTherapy
unit and exported to the Pinnacle3 treatment planning station. This was completed over a period of two
days. For each day an MVCT number-to-density table was created as mentioned in Aim 1. Figure 40
shows one of the masks on the plastic water® phantom.

(a)
(b)
Figure 40. (a) Beam’s eye view of Cerrobend® mask on top of CIRS plastic water® phantom. (b)
Lateral view of Cerrobend® on top of CIRS plastic water® phantom.
6.2.3 Density versus depth
The penetration of a radiation beam in a given material depends in part on the density of that
material. The density of an object that has been CT scanned is determined by converting the measured CT
number to a density according to a CT number-to-density calibration curve. Therefore, distortions in
imaging that cause changes in the CT numbers will result in corresponding density changes and
corresponding changes in calculated doses.
In order to assess the impact of the skin collimation on the distortion of density, density was
measured as a function of depth along the central axis of the treatment beams. Because of inherent noise in
the images, CT numbers were averaged within ROIs created on the kVCT image set and on each MVCT
image set to provide a mean density (Fig 41). A total of 16 ROIs were created on image sets with treatment
beams of 6-12 MeV and 20 ROIs were created on image sets with a 16 MeV beam. The ROIs were
cuboids with dimensions of 1x0.4 cm2 and a thickness equal to the slice thickness. The mean density was
computed in each of these ROIs using Pinnacle3 and assigned to the depth at the center of the ROI.
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Figure 41. Central axis ROIs on MVCT image.
The mean densities were also used to obtain a radiological depth versus dose curve along the
central axis. The radiological depth is defined as the sum over segments of the product of the segment
length and the inhomogeneity density of the region corresponding to the segment and was calculated at
each dose point by a simple equation (Siddon et al). The mean density of each ROI (ρROI), the physical
thickness of each ROI (∆d), and the physical depth at the center of each ROI (di) were used to compute the
radiological depth (deq, i) at the center of each ROI from the following equations:
for n=1

d eq ,1 =

∆d
* ρ ROI ,1
2

for n>1

d eq ,n = d eq ,1 + ∑i = 2
n

∆d
* {ρ ROI ,i −1 + ρ ROI ,i } .
2

The dose at the center of each ROI (Di) was calculated by Pinnacle3 and the radiological depth and dose
values were used to create the plot (Di vs. deq, i).

6.2.4 Dose extraction methods
Dose grids of identical dimensions were defined for all CT image sets. Then, the kVCT and
MVCT image sets were registered spatially by aligning the posterior edge of the dose grid to the posterior
edge of the plastic water® (Figure 42). The coordinate of the posterior edge of the plastic water® in both
CT sets was determined by the same two step process outlined in Aim 2. This method put the dose grid in
the same position relative to the phantom regardless of possible distortions in the anterior surface of the
images due to the skin collimation.
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Figure 42. The dose grid (green dash) on an MVCT image with the posterior edge at the posterior edge of
phantom.
After the matrices were imported into SigmaPlot® from the Pinnacle3 workstation, the depth dose
and isodose curves were aligned with respect to the back edge of the plastic water®, which corresponded to
the back edge of the dose grid. This assured that the 0 cm depth for the depth dose and isodose curves
corresponded to the surface of the plastic water® in the kVCT image set.
6.2.5 Treatment planning
A total of twelve treatments were planned on the nine different kVCT configurations and the nine
MVCT scanned image sets. Each plan contained an electron beam at an SSD of 100cm, with a prescription
of 100 monitor units and included the mask of corresponding size and thickness (Table 12).
Table 12. Treatment plans delivered to MVCT image sets.
Treatment plan
1
2
3
4
5
6
7
8
9
10
11
12

Opening size (cm2)
3x3
3x3
3x3
3x3
6x6
6x6
6x6
6x6
10x10
10x10
10x10
10x10

Beam energy (MeV)
6
9
12
16
6
9
12
16
6
9
12
16

Mask thickness (mm)
6
6
8
10
6
6
8
10
6
6
8
10

SSD (cm)
100
100
100
100
100
100
100
100
100
100
100
100

Central-axis depth dose curves and isodose curves were compared in the central axial xz-plane.
Doses were taken directly from the planning system. No normalizations were applied. Dose comparisons
were evaluated using the same criteria as used in Aims 2 and 3. In the uniform-dose region, dose
differences were computed and in high dose-gradient regions, distance-to-agreement (DTA) was measured.
The maximum dose difference in the uniform region was calculated by subtracting the MVCT calculated
dose matrix from the kVCT calculated dose matrix. The DTAs were measured on superimposed hard
copies of isodose plots for each opening and energy. It is noted that there are some large discrepancies in
the penumbra region just lateral to the edges of the skin collimation. This is due in part to the fact that the
Pinnacle3 pencil beam algorithm has pencil beams that are 2x2 mm2. This means that there is a ±1 mm
uncertainty in position of the calculated doses at the edge of the beam. Also, the MVCT images show some
distortion at the edges of the Cerrobend® mask. They appear slightly rounded when in fact the edges are
straight (Fig 43). This adds to the uncertainty in calculated dose at the edge of the collimation.
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MUs
100
100
100
100
100
100
100
100
100
100
100
100

rounded edge
Figure 43. Axial MVCT image showing distorted (rounded) edges of Cerrobend® skin collimation (3x3
cm2, 10 mm).
6.3 Results
6.3.1 Small opening (3x3 cm2)
Overlays of the MVCT and kVCT isodose distributions are shown in Figs 44-47. The central axis
depth doses are shown in Figs 48-51. Table 12 gives the range of dose differences in the uniform-dose
region. There is no instance in which the maximum dose differences meet the hypothesis criterion. All
cases fail to meet the criterion and the maximum error is largest in the 12 MeV case, which is the energy
with the highest peak in dose along the central axis.
The maximum DTAs in the high dose-gradient regions are also shown in Table 13. In no instance
are they within ±2 mm. For the 12 MeV and 16 MeV beams, the maximum DTAs are well above ±2 mm.
In addition, the maximum DTA also increases with increasing beam energy.
Table 13. Ranges of dose differences for the 3x3 cm2 opening in the uniform-dose region and maximum
DTAs in high dose-gradient regions.

3x3cm2
opening
6 MeV
9 MeV
12 MeV
16 MeV

Ranges of dose differences (%)
(uniform-dose region)
2.8, -6.3
2.7, -6.7
5.0, -11.8
5.9, -7.5

Maximum DTA (mm)
(gradient regions)
3.2
4.0
6.3
7.3

The central-axis depth doses highlight some aspects of the comparison that are not readily
apparent in the maximum dose differences and maximum DTA measurements. The depth doses show a
decreasing penetration of the beam in the MVCT images relative to the kVCT images as the energy
increases. In addition, there is a peaking phenomenon for the MVCT calculated doses. The highest peak
occurs for the 12 MeV beam and the longest peak occurs for the 16 MeV beam. This peaking is unique to
the small opening case and will be discussed in the analysis section.
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Figure 44. MVCT and kVCT calculated isodose comparison (3x3 cm2, 6 MeV).

Figure 45. MVCT and kVCT calculated isodose comparison (3x3 cm2, 9 MeV).
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Figure 46. MVCT and kVCT calculated isodose comparison (3x3 cm2, 12 MeV).

Figure 47. MVCT and kVCT calculated isodose comparison (3x3 cm2, 16 MeV).
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Figure 48. MVCT and kVCT calculated depth dose curve comparison (3x3 cm2, 6 MeV).
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Figure 49. MVCT and kVCT calculated depth dose curve comparison (3x3 cm2, 9 MeV).
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Figure 50. MVCT and kVCT calculated depth dose curve comparison (3x3 cm2, 12MeV).
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Figure 51. MVCT and kVCT calculated depth dose curve comparison (3x3 cm2, 16 MeV).
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6.3.2 Medium opening (6x6cm2)
Overlays of the MVCT and kVCT isodose distributions are shown in Figs 52-55. Depth dose
curves along the central axis are shown in Figs 56-59. Table 14 gives the range of dose differences in the
uniform-dose region. The maximum dose differences fail to meet the hypothesis criterion (±5%) for all
beams. The maximum DTAs in the high dose-gradient regions fail to be within ±2 mm for all energies
(Table 14). However, the maximum DTAs clearly agree much better than those of the small opening.
Table 14. Ranges of dose differences for the 6x6cm2 opening in the uniform-dose region and maximum
DTAs in high dose-gradient regions.

6x6cm2
opening
6 MeV
9 MeV
12 MeV
16 MeV

Ranges of dose
differences (%)
(uniform-dose
region)
6.3, -5.3
5.2, -7.6
5.1, -2.6
3.2, -13.7

Maximum DTA (mm)
(gradient regions)
2.7
3.0
3.7
3.7

Comparison of the central-axis depth dose curves shows very good agreement in the penetration of
the higher energy beams. Similar to the 3x3 cm2 opening MVCT depth dose curves, the curves for this
opening penetrate less deeply than those of the kVCT. However, in this case, the curves agree much better
especially for the lower energies. There also appears to be less variation in the difference with beam
energy. It should be noted that in the low energy range (6-12 MeV) there is none of the peaking that
occurred for the small opening beams. A slight peak occurs in the high energy (16 MeV) beam and this
will be discussed in the analysis section.
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Figure 52. MVCT and kVCT calculated isodose comparison (6x6 cm2, 6 MeV).

Figure 53. MVCT and kVCT calculated isodose comparison (6x6 cm2, 9 MeV).
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Figure 54. MVCT and kVCT calculated isodose comparison (6x6 cm2, 12 MeV).

Figure 55. MVCT and kVCT calculated isodose comparison (6x6 cm2, 16 MeV).
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Figure 56. MVCT and kVCT calculated depth dose curve comparison (6x6 cm2, 6 MeV).
.
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Figure 57. MVCT and kVCT calculated depth dose curve comparison (6x6 cm2, 9 MeV).
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Figure 58. MVCT and kVCT calculated depth dose curve comparison (6x6 cm2, 12 MeV).
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Figure 59. MVCT and kVCT calculated depth dose curve comparison (6x6 cm2, 16 MeV).
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6.3.3 Large opening (10x10cm2)
Overlays of the MVCT and kVCT isodose distributions are shown in Figs 60-63). Depth dose
curves along the central axis are shown in Figs 64-67. Table 15 gives the range of dose differences in the
uniform-dose region. In all cases, the maximum dose differences exceeded ±5%. The maximum dose
differences appear to be essentially independent of beam energy.
The maximum DTA was greater than ±2 mm for all energies except 16MeV (Table 15). However,
the low energies (6, 9MeV) were close to meeting the hypothesis criterion.
Table 15. Ranges of dose differences for the 10x10 cm2 opening in the uniform-dose region and maximum
DTAs in high dose-gradient regions.
2

10x10cm
opening
6 MeV
9 MeV
12 MeV
16 MeV

Ranges of dose
differences (%)
(uniform-dose region)
4.8, -5.4
3.9, -5.5
4.5, -1.1
4.9, -2.8

Maximum DTA (mm)
(gradient regions)
2.0
2.0
2.3
1.7
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Figure 60. MVCT and kVCT calculated isodose comparison (10x10 cm2, 6 MeV).

Figure 61. MVCT and kVCT calculated isodose comparison (10x10 cm2, 9 MeV).
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Figure 62. MVCT and kVCT calculated isodose comparison (10x10 cm2, 12 MeV).

Figure 63. MVCT and kVCT calculated isodose comparison (10x10 cm2, 16 MeV).
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The shapes of the MVCT and kVCT central-axis depth dose curves (Figs 64-67) are very similar
but the MVCT curves are shifted to greater depth. The amount of shift appears to be essentially
independent of beam energy. In addition, there is no peaking in the MVCT calculated dose as was seen for
the small opening beams.

Figure 64. MVCT and kVCT calculated depth dose curve comparison (10x10 cm2, 6 MeV).

6.3.4 Density versus depth plots
In Figures 68-70, the mean density in ROIs along the central axis is shown as a function of depth
for the different mask openings and thicknesses. For comparison, the mean density in ROIs along the
central axis as a function of depth is shown for the kVCT image without skin collimation.
For the small opening, mean densities along the central axis are much higher than the
corresponding kVCT densities reaching a maximum increase of about 10% over kVCT values for the 10
mm mask. The MVCT densities show a slight trend toward increasing values with increasing mask
thickness.
For the medium opening central axis densities are slightly higher in the MVCT images compared
to the kVCT images. The maximum density for the MVCT images is only approximately 3% higher than
the kVCT values. There is little variation in density with mask thickness except at the most superficial
depths (0-2 cm).
For the large opening, the mean MVCT densities are slightly lower than the kVCT densities at the
superficial depths (0-3.5 cm). At 1-3 cm depth, they are as much as 3% low. In that depth range, there is
some variation in density with mask thickness. At greater depths (>6cm), the MVCT densities are slightly
greater than the kVCT densities, but too deep to affect electron doses.
It is interesting that the density versus depth curves seem to have two plateaus. Up to about 4 cm
depth, the MVCT densities show a larger variation with opening size than at greater depths. This suggests
that the skin collimation produces greater distortions at shallower depths, not a surprising result.
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Figure 65. MVCT and kVCT calculated depth dose curve comparison (10x10 cm2, 9 MeV).

53

Figure 66. MVCT and kVCT calculated depth dose curve comparison (10x10 cm2, 12 MeV).
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Figure 67. MVCT and kVCT calculated depth dose curve comparison (10x10 cm2, 16 MeV).
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Figure 68. Density versus depth curve for the 3x3 cm2 opening.

Density (g·cm-3)

Figure 69. Density versus depth curve 6x6 cm2 opening.

Figure 70. Density versus depth curve 10x10 cm2 opening.
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6.3.5 Dose versus radiological depth
To more directly examine the effects of density distortion on calculated dose, dose was plotted as a
function of radiological depth along the central-axis of each beam (Fig 71-82). Radiological depth was
computed from mean densities as described in the Methods and Material.
6.4 Analysis of results
With one exception, dose calculations in the MVCT images differed from the kVCT dose
calculations by more than ±5% in the uniform-dose region for all opening sizes. Agreement in the gradient
regions was better but still exceeded a distance-to-agreement of ±2 mm in 9 of the 12 plans. The large
opening showed the best agreement in the gradient regions.
In examining the depth dose curves for each of the opening sizes, it is clear that the shift of the
MVCT curve relative to the kVCT curve varies with the size of the opening. For the small opening, the
MVCT curves are greatly shifted to shallow depths. For the medium opening, the MVCT curves are
shifted to more shallow depths but more closely match the kVCT curves. For the large opening, the MVCT
curves are shifted to greater depths. A peak was also observed in the small opening results as well as a
small peak in the high energy (16 MeV) case for the medium opening. These are two separate issues and
will be discussed separately.
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Figure 71. Dose versus radiological depth (3x3 cm2 opening, 6 MeV).
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Figure 72. Dose versus radiological depth (3x3 cm2 opening, 9 MeV).
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Figure 73. Dose versus radiological depth (3x3 cm2 opening, 12 MeV).
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Figure 74. Dose versus radiological depth (3x3 cm2 opening, 16 MeV).
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Figure 75. Dose versus radiological depth (6x6 cm2 opening, 6 MeV).
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Figure 76. Dose versus radiological depth (6x6 cm2 opening, 9 MeV).
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Figure 77. Dose versus radiological depth (6x6 cm2 opening, 12 MeV).
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Figure 78. Dose versus radiological depth (6x6 cm2 opening, 16 MeV).
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Figure 79. Dose versus radiological depth (10x10 cm2 opening, 6 MeV).
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Figure 80. Dose versus radiological depth (10x10 cm2 opening, 9 MeV).
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Figure 81. Dose versus radiological depth (10x10 cm2 opening, 12 MeV).
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Figure 82. Dose versus radiological depth (10x10 cm2 opening, 16 MeV).
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6.4.1 Shifted MVCT curves
The dose shift to shallower depths for the small and medium openings and the shift to greater
depth for the large opening are due to CT number distortions in the images caused by the presence of
Cerrobend®. These distortions in the CT numbers produce distortions in the density of the material, which
cause the electron beam penetration to change depending on the amount of distortion. The density versus
depth plots shown in section 6.3.4 clearly reveal this effect. Displaying radiological depth versus dose
removes the effect of distortions in the densities of the phantom. The plots of dose versus radiological
depth confirm that most, but not all, of the dose differences result from these distortions. For the medium
and large openings, these plots are almost identical for the MVCT and kVCT images, confirming that these
dose differences are due almost entirely to density distortions in the MVCT images of the phantom.
For the small opening, these density distortions contribute to the dose differences but are not the
only effect. Comparing the plots of dose versus radiological depth (Figs 75-77) to the corresponding plots
of dose versus depth (Figs 52-54) show that removing the distortions in the phantom MVCT numbers
improves the agreement. However, significant differences remain. The remaining significant differences
are caused by the second issue, that of peaking.
6.4.2 Peaking in the small opening data
The residual dose differences are attributed to distortions in the images of the skin collimation in
the MVCT scans. In the MVCT images, the internal edges of the skin collimation appear slightly rounded,
when they are in fact straight (Figure 46). This artificial rounding causes the dose calculation algorithm to
overestimate the number of electrons scattered from this inner edge. The extra scattered electrons deposit
their dose at superficial depths, including Dmax, and so do not penetrate to the depth that they would if the
collimation were accurately represented. This additional scattering from the edge of the collimation can be
seen in the isodose plots of the larger openings as well. There are two hot spots located lateral to the
central-axis in every one of the isodose plots for the 6x6 cm2 and 10x10 cm2 opening beams except for that
of the 16 MeV beam, 10x10 cm2 opening size (Figs 55-58, 59-61) . The depth dose plots for the medium
and large openings are not affected simply because the width of the openings is too great for the collimatorscattered electrons to reach the center of the field. The one exception is seen in the high energy (16 MeV),
with medium opening case where the electrons had enough energy to reach the central axis after being
scattered off the collimator. These changes in dose from distortion in the image of the collimator are in
addition to dose changes due to distortions in the image of the phantom.
6.5 Summary
Two different effects contribute to the discrepancies between MVCT computed doses and kVCT
computed doses. The dominant effect is the distortion in density in the MVCT images caused by the highdensity Cerrobend®. Although not readily apparent in the MVCT images, the CT numbers below the
openings in the path of the beam are changed by the presence of the skin collimation. For the smallest
opening, the distortion in CT numbers appears as tissue density increases of up to 10%. With increasing
opening size, the CT numbers decrease, producing smaller apparent density shifts. Therefore, the electron
beam penetration changes with opening size. A second effect is the distortion of the image of the skin
collimation. This distortion causes increases in superficial dose and decreases in dose at depth.
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Chapter 7 Conclusion
The hypothesis of this research is that using MVCT images with skin collimation for treatment
planning, doses delivered from 6-16 MeV electron beams can be calculated to ±5% dose difference
agreement in the uniform-dose region and ±2mm distance-to-agreement in high dose-gradient regions to
doses calculated using kVCT images with manually contoured skin collimation. The uniform dose region
is defined as those doses >90% of the maximum dose along the central-axis for a 10x10 cm2 open field at
100 cm SSD and the high dose-gradient region is defined as 10%<doses<90% of the maximum dose along
the central-axis for a 10x10 cm2 open field at 100 cm SSD.
This hypothesis was tested with five specific aims and two related but distinct goals. Aims 2 and
3 tested the ability of MVCT images to be used for treatment planning with electron beams without the
presence of skin collimation. Aim 5 tested the ability of MVCT images to be used for treatment planning
with electron beams with skin collimation present.
It was found that doses calculated using MVCT images agreed well with doses calculated using
kVCT images when there was no skin collimation. It was sufficiently accurate to meet the criteria of the
hypothesis for the simple geometry phantom and the head phantom. It failed for the patient case, but that
may have been due to changes in anatomy during the 2 month interval between the scans.
When skin collimation was introduced into the MVCT images, the distortions in the phantom
density and distortions in the image of the skin collimation produced errors that were greater than ±5% and
maximum DTAs that were greater than ±2 mm in most cases.
The results of this research negate the hypothesis that using MVCT images for treatment planning,
doses delivered from 6-16 MeV electron beams can be calculated with the presence of skin collimation to
±5% dose difference in the uniform dose region and ±2 mm DTA in dose gradient regions. Therefore, the
hypothesis must be rejected.
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